Impairment of triptolide on liver mitochondria in isolated liver mitochondria and HL7702 cell line

Chinese Journal of Integrative Medicine

Volumn 19, Issue 9, 2013, Pages 683-688

  Fu, Qiang ^a   Jiang, Zhen Zhou ^a   Zhang, Lu Yong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

hepatotoxicity; mitochondria; triptolide

Indexed keywords

5,5',6,6 -TETRACHLORO 1,1',3,3' TETRAETHYLBENZIMIDAZOLYLCARBOCYANINE IODIDE; FLUORESCENT DYE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE; TRIPTOLIDE; UNCLASSIFIED DRUG;

ABSORPTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; EXCITATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; ISOLATED LIVER; LIVER CELL; LIVER MITOCHONDRION; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION SWELLING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE; DITERPENES; EPOXY COMPOUNDS; FEMALE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, LIVER; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL SWELLING; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84883287682     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-1265-x     Document Type: Article

References (26)

1. Tao X, Davis LS, Lipsky PE. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthrit Rheum 1991;34:1274-1281.
2. Tao X, Lipsky PE. The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am 2000;26:29-50, viii.
3. Takaishi Y, Ujita K, Tokuda H, Nishino H, Iwashima A, Fujita T. Inhibitory effects of dihydroagarofuran sesquiterpenes on Epstein-Barr virus activation. Cancer Lett 1992;65:19-26.
4. Li XY. Anti-inflammatory and immunosuppressive components of Tripterygium wilfordii Hook F. Int J Immunother 1993;9:181-187.
5. Yao W-C, Nian H-F. Medicated wine of Tripterygium wilfordii in treating rheumatoid arthritis in 392 patients. Pharmaceut Clin Res (Chin) 2004;23:35-37.
6. Shamon LA, Pezzuto JM, Graves JM, Mehta RR, Wangcharoentrakul S, Sangsuwan R, et al. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett 1997;112:113-117.
7. Zheng J. Screening of active anti-inflammatory, immunosuppressive and antifertility components from Tripterygium wilfordii. IV. A comparison of the male antifertility activities of 7 diterpene lactone epoxide compounds. Acta Acad Med Sin (Chin) 1991;13:398-403.
8. Zheng J. Screening of active anti-inflammatory, immunosuppressive and antifertility components of Tripterygium wilfordii. III. A comparison of the antiinflammatory and immunosuppressive activities of 7 diterpene lactone epoxide compounds in vivo. Acta Acad Med Sin (Chin) 1991;13:391-397.
9. Tao X, Cai JJ, Lipsky PE. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook F. J Pharmacol Exp Ther 1995;272:1305-1312.
10. Tao X, Schulze-Koops H, Ma L, Cai J, Mao Y, Lipsky PE. Effects of Tripterygium wilfordii Hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthrit Rheum 1998;41:130-138.
11. Duan H, Takaishi Y, Momota H, Ohmoto Y, Taki T, Jia Y, et al. Immunosuppressive sesquiterpene alkaloids from Tripterygium wilfordii. J Nat Prod 2001;64:582-587.
12. Duan H, Takaishi Y, Momota H, Ohmoto Y, Taki T, Tori M, et al. Immunosuppressive terpenoids from extracts of Tripterygium wilfordii. Tetrahedron 2001;57:8413-8424.
13. Brinker AM, Ma J, Lipsky PE, Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 2007;68:732-766.
14. Song HX, Gong J, Chen W. Effect of triptolide on urinary monocyte chemottractant protein-1 in patients with diabetic nephropathy. Chin J Integr Tradit West Med (Chin) 2005;25:416-418.
15. Peng A, Gu Y, Lin SY. Herbal treatment for renal diseases. Ann Acad Med Singapore 2005;34:44-51.
16. Wu SX, Guo NR. Clinical observation on effect of triptolide tablet in treating patients with psoriasis vulgaris. Chin J Integr Med 2005;11:147-148.
17. Yao J, Jiang Z, Duan W, Huang J, Zhang L, Hu L, et al. Involvement of mitochondrial pathway in triptolide-induced cytotoxicity in human normal liver L-02 cells. Biol Pharm Bull 2008;31:592-597.
18. Shu B, Duan W, Yao J, Huang J, Jiang Z, Zhang L. Caspase 3 is involved in the apoptosis induced by triptolide in HK-2 cells. Toxicol In Vitro 2009;23:598-602.
19. Liu L, Jiang Z, Liu J, Huang X, Wang T, Zhang Y, et al. Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats. Toxicology 2010;271:57-63.
20. Ni B, Jiang Z, Huang X, Xu F, Zhang R, Zhang Z, et al. Male reproductive toxicity and toxicokinetics of triptolide in rats. Arzneimittelforschung 2008;58:673-680.
21. Ni B, Zhu T, Jiang Z, Zhang R, Zhang T, Zhang L. In vitro and in silico approaches for analyzing the toxicological effect of triptolide on cx43 in sertoli cells. Toxicol Mech Methods 2008;18:717-724.
22. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;349:474-485.
23. Pessayre D, Mansouri A, Berson A, Fromenty B. Mitochondrial involvement in drug-induced liver injury. Handb Exp Pharmacol 2010:311-365.
24. Fromenty B, Pessayre D. Inhibition of mitochondrial betaoxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995;67:101-154.
25. Pessayre D, Mansouri A, Haouzi D, Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999;15:367-373.
26. Su Y, Yang S, Xiao Z, Wang W, Okunieff P, Zhang L. Triptolide alters mitochondrial functions. Adv Exp Med Biol 2007;599:139-146.